BioCentury
ARTICLE | Clinical News

AS1402: Phase II started

October 6, 2008 7:00 AM UTC

Antisoma began an open-label, international Phase II trial to evaluate letrozole with or without intravenous AS1402 as first-line therapy in 110 post-menopausal women. ...